ProKidney Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
ProKidney Corp. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.080.000.000.000.00
Cost of Revenue0.000.000.000.000.00
Gross Profit0.080.000.000.000.00
Operating Expenses
Research & Development127.67106.7182.0746.2621.04
Selling, General & Administrative56.0844.8270.948.865.98
Operating Expenses183.75151.52153.0155.1127.02
Operating Income-183.68-151.52-153.01-55.11-27.02
Other Income/Expense
Interest Income19.7522.085.980.000.04
Interest Expense0.01-0.010.220.000.00
Other Income/Expense19.740.000.000.000.00
Income
Income Before Tax-163.93-129.45-147.24-55.11-26.98
Income Tax Expense-0.606.000.900.04-0.23
Net Income-61.19-35.47-108.03-55.15-26.75
Net Income - Continuous Operations-61.19-135.45-148.14-55.150.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-158.49-147.67-143.99-53.12-26.06
EBIT-178.35-151.52-147.02-55.11-27.02
Depreciation & Amortization5.433.853.041.980.96
Earnings Per Share
Basic EPS-1.00-1.00---
Diluted EPS-1.00-1.00---
Basic Shares Outstanding97.9261.7161.54186.50104.99
Diluted Shares Outstanding97.9261.7161.54186.50104.99